Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Hydrocodone IR by Elysium Therapeutics for Opium (Opioid) Addiction: Likelihood of Approval
Hydrocodone IR is under clinical development by Elysium Therapeutics and currently in Phase I for Opium (Opioid) Addiction. According to...
Data Insights
KNX-100 by Kinoxis Therapeutics for Opium (Opioid) Addiction: Likelihood of Approval
KNX-100 is under clinical development by Kinoxis Therapeutics and currently in Phase I for Opium (Opioid) Addiction. According to GlobalData,...